Drug trial results show lung cancer patients are living longer
21 June, 2024Five years after treatment, 60% of patients treated with lorlatinib remained alive and without disease progression; this compared to just 8% for patients who received crizotinib.
Bionic eye recipients demonstrate clear vision improvements
20 June, 2024Results from a clinical trial of a second-generation bionic eye have demonstrated substantial improvement in four participants' functional vision, daily activities and quality of life.
WEHI launches spinout company to tackle hard-to-treat cancers
19 June, 2024The technology that Ternarx is pursuing has huge potential to create the next generation of treatments for cancer and other diseases that are currently untreatable.
Queensland Emory Vaccine Centre to be established at UQ
11 June, 2024The centre will bring together UQ and Emory researchers, along with industry partners, to accelerate the development of vaccines and their delivery.
Magnetic therapy helps to protect against cancer
06 June, 2024A novel approach to stimulate muscle — by using brief and mild pulsed electromagnetic field exposure — has been used to produce and release proteins possessing anticancer properties.
Nano carrier could enable oral insulin for diabetics
28 May, 2024A new form of oral insulin utilises a nanoscale material that surrounds individual insulin molecules, acting like a courier to ferry these molecules to the places they need to act.
Gentler form of IVF found to improve success rates
27 May, 2024The 'soft touch' technique, known as Piezo-ICSI, works by gently penetrating an egg using high-speed vibration, rather than the standard cutting action used in conventional ICSI.
Towards the next generation of vision implants
13 May, 2024An ultrasmall implant, with electrodes the size of a single neuron that can remain intact in the human body, holds promise for future vision implants for the blind.
New anti-clotting agent has its own 'off switch'
10 May, 2024The anticoagulant's anti-clotting action can be rapidly stopped on demand, which could enable new surgical and post-operative drugs that minimise the risk of serious bleeding.
One-two punch treatment knocks out acute myeloid leukaemia
08 May, 2024Researchers paired venetoclax, a current standard-of-care anticancer drug for acute myeloid leukaemia, with a STING agonist, an emerging class of immunotherapy drug.
Creating self-assembling capsules for drug delivery
07 May, 2024Scientists have created nanosized capsules that could be used to deliver drugs and messenger RNA (mRNA), a molecule that instructs cells to produce proteins.
Hybrid insulin pumps work well for type 1 diabetes
03 May, 2024Advanced hybrid closed loop (AHCL) insulin pumps are designed to constantly measure blood sugar levels, using specific algorithms to dose insulin and automatically keep blood sugar levels in check.
3D-printed films provide targeted liver cancer treatment
01 May, 2024Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer cells while minimising the systematic toxicities of traditional chemotherapy.
Repurposed drugs show promise in heart muscle regeneration
26 April, 2024The FDA-approved medications, when given in combination, target two proteins that regulate the heart muscle's regeneration capabilities.
RNA-targeted therapy shows promise for childhood dementia
22 April, 2024Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type of childhood dementia in mice.
